Skip to main content
Feasibility of an implantable bioreactor for renal cell therapy using silicon nanopore membranes.
UHRF1 is a mediator of KRAS driven oncogenesis in lung adenocarcinoma.
Etiology of oncogenic fusions in 5,190 childhood cancers and its clinical and therapeutic implication.
Loss of phosphatase CTDNEP1 potentiates aggressive medulloblastoma by triggering MYC amplification and genomic instability.
Smarcd3 is an epigenetic modulator of the metabolic landscape in pancreatic ductal adenocarcinoma.
Systematic analysis and prediction of genes associated with monogenic disorders on human chromosome X.
Integrated stem cell signature and cytomolecular risk determination in pediatric acute myeloid leukemia.
Single-cell analysis of hepatoblastoma identifies tumor signatures that predict chemotherapy susceptibility using patient-specific tumor spheroids.
Author Correction: Cross-reactive immunity against the SARS-CoV-2 Omicron variant is low in pediatric patients with prior COVID-19 or MIS-C.
Evaluation of transplacental transfer of mRNA vaccine products and functional antibodies during pregnancy and infancy.